Serum albumin level accurately reflects antioxidant potentials in idiopathic nephrotic syndrome

Clinical and Experimental Nephrology

Volumn 16, Issue 3, 2012, Pages 411-414

  Kaneko, Kazunari ^a   Kimata, Takahisa ^a   Tsuji, Shoji ^a   Shimo, Tomohiko ^a   Takahashi, Masaya ^a   Tanaka, Sachiyo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Albumin; Antioxidant; Idiopathic nephrotic syndrome; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ANAPHYLACTOID PURPURA; ARTICLE; BIOCHEMISTRY; BIOLOGICAL ANTIOXIDANT POTENTIAL; C REACTIVE PROTEIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; HUMAN CELL; HYPOALBUMINEMIA; NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELAPSE; REMISSION;

ADOLESCENT; ADULT; ANTIOXIDANTS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; HUMANS; NEPHROTIC SYNDROME; OXIDATIVE STRESS; PURPURA, SCHOENLEIN-HENOCH; RECURRENCE; SERUM ALBUMIN;

EID: 84863717722     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0578-y     Document Type: Article

References (15)

1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629-39.
2. Hingorani SR, Weiss NS, Watkins SL. Predictors of peritonitis in children with nephrotic syndrome. Pediatr Nephrol. 2002;17: 678-82.
3. Uncu N, Bülbül M, Yildiz N, Noyan A, Koşan C, Kavukçu S, et al. Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr. 2010;169: 73-6.
4. Haynes GR, Navickis RJ, Wilkes MM. Albumin administration-what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol. 2003;20: 771-93.
5. Chen TA, Tsao YC, Chen A, Lo GH, Lin CK, Yu HC, et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44: 619-25.
6. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783-7.
7. Nishikawa T, Okamoto Y, Kodama Y, Tanabe T, Shinkoda Y, Kawano Y. Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever. Pediatr Blood Cancer. 2010;55:91-4.
8. El-Melegy NT, Mohamed NA, Sayed MM. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. Pediatr Res. 2008;63:404-9.
9. Ece A, Atamer Y, Gürkan F, Davutolu M, Koçyiit Y, Tutanç M. Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2005;20:1279-84.
10. Karthikeyan K, Sinha I, Prabhu K, Bhaskaranand N, Rao A. Plasma protein thiols and total antioxidant power in pediatric nephrotic syndrome. Nephron Clin Pract. 2008;110:c10-4.
11. Dogra G, Ward N, Croft KD, Mori TA, Barrett PH, Herrmann SE, Irish AB, Watts GF. Oxidant stress in nephrotic syndrome: Comparison of F(2)-isoprostanes and plasma antioxidant potential. Nephrol Dial Transpl. 2001;16:1626-30.
12. Kamireddy R, Kavuri S, Devi S, Vemula H, Chandana D, Harinarayanan S, et al. Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta. 2002;325:147-50.
13. Natarajan SK, Mukhopadhya A, Ramachandran A, Amalanathan S, Kurian G, Balasubramanian KA. Spontaneous bacterial peritonitis results in oxidative and nitrosative stress in ascitic fluid. J Gastroenterol Hepatol. 2007;22:177-81.
14. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol. 2001;16:607-12.
15. Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of alpha 1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int. 1992;42:735-42.